CICC Wealth invests in YiChang HEC shares amid merger

On July 7, CICC Wealth Investment Limited disclosed dealings in YiChang HEC ChangJiang Pharmaceutical shares, according to Rule 22 of the Hong Kong Code on Takeovers and Mergers. The transactions, conducted on July 4, involved both the purchase and sale of securities. The purchase transaction involved 1,200 shares at a total cost of HKD16,877.7000, with prices paid at HKD14.0648. Simultaneously, the firm sold 1,200 shares for HKD16,896.5700, receiving prices at HKD14.0805. These dealings were related to closing or unwinding proprietary positions arising from unsolicited client-driven dealings. CICC Wealth Investment is an exempt principal trader connected with the Offeror and is ultimately owned by China International Capital Corporation Limited.